BAUSCH HEALTH COS./ CA0717341071 /
| 2024-12-21 1:03:47 PM | Chg. 0.000 | Volume | Bid1:03:47 PM | Ask1:03:47 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 7.090EUR | 0.00% | - Turnover: - |
7.090Bid Size: - | 7.230Ask Size: - | 2.63 bill.EUR | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,466 | 1,567 | 1,598 | 1,600 | 1,707 | ||||||
| Intangible Assets | 10,201 | 8,445 | 6,948 | 5,800 | 6,456 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 26,894 | 25,857 | 23,595 | 21,439 | 21,754 | ||||||
| Inventories | 1,107 | 1,094 | 993 | 1,090 | 1,544 | ||||||
| Accounts Receivable | 1,839 | 1,577 | 1,775 | 1,790 | 1,998 | ||||||
| Cash and Cash Equivalents | 3,243 | 605 | 582 | 564 | 947 | ||||||
| Current Assets | 6,969 | 5,342 | 5,607 | 4,247 | 5,596 | ||||||
| Total Assets | 33,863 | 31,199 | 29,202 | 25,686 | 27,350 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 503 | 337 | 407 | 521 | 719 | ||||||
| Long-term debt | 24,661 | 23,925 | 22,654 | 20,334 | 21,938 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 5,216 | - | - | - | - | ||||||
| Liabilities | 32,727 | 30,594 | 29,236 | 25,426 | 27,432 | ||||||
| Share Capital | 10,172 | 10,227 | 10,317 | 10,391 | 10,423 | ||||||
| Total Equity | 1,136 | 605 | -34 | 260 | -82 | ||||||
| Minority Interests | 73 | 70 | 72 | 952 | 940 | ||||||
| Total liabilities equity | 33,863 | 31,199 | 29,202 | 25,686 | 27,350 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 8,601 | 8,027 | 8,434 | 8,124 | 8,757 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -203 | 676 | 450 | 454 | 963 | ||||||
| Interest Income | 12 | 13 | 7 | 14 | 26 | ||||||
| Income Before Taxes | -1,837 | -934 | -1,024 | -129 | -390 | ||||||
| Income Taxes | 54 | 375 | 87 | -83 | -221 | ||||||
| Minority Interests Profit | -5 | -1 | -11 | -13 | 19 | ||||||
| Net Income | -1,788 | -560 | -948 | -225 | -592 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,501 | 1,111 | 1,426 | -728 | 1,032 | ||||||
| Cash Flow from Investing Activities | -419 | -261 | 409 | -303 | -2,145 | ||||||
| Cash Flow from Financing | 1,443 | -2,294 | -1,513 | -474 | 1,475 | ||||||
| Decrease / Increase in Cash | 2,521 | -1,428 | 303 | -1,528 | 371 | ||||||
| Employees | 21,700 | - | - | - | - | ||||||
